Similarly, CRTH2 blockade with selective antagonist CAY10595 protected hearts from MI as evidenced by increasing heart functions (Fig EV2A–C) and reducing infarction sizes of hearts (Fig EV2D–E). This evidence concerns the gene PTGDR2 and infarction.